Artificial intelligence in medicine promises to alert us to disease or a medical emergency before it happens—if only we can navigate the pitfalls.
Powered by WPeMatico
Less BS, More Facts, Some Opinions
Powered by WPeMatico
Powered by WPeMatico
April 17, 2018
[Read More …]
Powered by WPeMatico
Acxiom intends to sell its marketing solutions division before moving to a potential sale of LiveRamp, because it believes selling them separately will drive more shareholder value, said sources close to the company. Interest in Acxiom and LiveRamp in particular heated up in March, after Salesforce bought the middleware tech company MuleSoft for $6.5 billion,… Continue reading »
The post Acxiom Working Out How To Maximize Value From A LiveRamp Sale appeared first on AdExchanger.
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico